Top
Begin typing your search above and press return to search.
keyboard_arrow_down
Login
exit_to_app
Arnabs chats cannot be ignored
access_time 2021-01-18T11:33:12+05:30
Women and girls need to be safe
access_time 2021-01-15T15:08:45+05:30
Another Trump impeachment
access_time 2021-01-15T11:16:29+05:30
Covid 19 spread
access_time 2021-01-14T15:40:30+05:30
DEEP READAll arrow_drop_down
Anti-Conversion Law: A law meant for abuse
access_time 2021-01-12T13:56:35+05:30
Syed Shahriyaar
access_time 2021-01-05T19:08:46+05:30
Reading A week in the life of Svitlana
access_time 2020-12-23T12:06:42+05:30
Hum Dekhenge- One year of Anti-CAA protests
access_time 2020-12-22T17:35:06+05:30
The French Fanatic and the Fanatic Fringe
access_time 2020-11-02T15:56:00+05:30
exit_to_app
Homechevron_rightLifestylechevron_rightHealthchevron_rightCovid vaccine to be...

Covid vaccine to be available in the country by January: Serum Institute

text_fields
bookmark_border
Covid vaccine to be available in the country by January:  Serum Institute
cancel

In an interview with NDTV, Serum Institute of India (SII) CEO Adar Poonawalla announced that Covishield vaccine developed by Oxford-AstraZeneca is expected to be available in the country by January 2021. SII is in talks with the government for mass-production of the vaccine and if approved, around 100 million doses of the vaccine will be available by January, he added.

AstraZeneca earlier announced that Covishield has been proved 90 per cent effective without any side effects in tests conducted in England and Brazil.

"We are putting an MRP of Rs 1,000–for the private market and Rs 250 or less for the government," the Poonawalla told NDTV.

The vaccine will initially be available to one million health workers. The government aims to make around 300 to 400 million doses available by July.

Show Full Article
TAGS:Covid vaccine Serum institute 
Next Story